✦ LIBER ✦

Expression of membrane and epithelial antigens in xenografts of an adenoid cystic carcinoma of the parotid gland

✍ Scribed by J. Ebbers; P. Koldovsky; U. Koldovsky

Book ID: 112785701
Publisher: Springer-Verlag
Year: 1986
Tongue: English
Weight: 129 KB
Volume: 111
Category: Article
ISSN: 1432-1335
DOI: 10.1007/bf02580252

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cystic Basal Cell Adenoma of the Parotid

Cystic Basal Cell Adenoma of the Parotid Gland with an Adenoid Cystic Carcinoma-like Structure

✍ Masakatsu Fukuda; Masaru Miyata; Koichi Okabe; Hiroshi Kurumaya; Kouichi Nagao; 📂 Article 📅 2003 🏛 Scientific Communications 🌐 English ⚖ 439 KB

Response to metronomic chemotherapy in a

Response to metronomic chemotherapy in a metastatic adenoid cystic carcinoma of the Parotid Gland

✍ Laura Visa; Miguel Caballero; Juan J. Grau 📂 Article 📅 2010 🏛 Elsevier ⚖ 264 KB

Complete response of a metastatic adenoi

Complete response of a metastatic adenoid cystic carcinoma of the parotid gland to chemotherapy

✍ Joseph L. Skibba; John D. Hurley; Henry V. Ravelo 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 796 KB

An apparent radiation-induced carcinoma

An apparent radiation-induced carcinoma of the parotid gland following treatment for adenoid cystic carcinoma of the sublingual gland: A case report

✍ Hisao Shigematsu; Seishi Magoshi; Seiji Suzuki; Kaoru Kusama; Hideaki Sakashita 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 948 KB

Arterio-venous malformation of parotid g

Arterio-venous malformation of parotid gland hiding occult adenoid cystic carcinoma in an eight-year-old girl

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Proliferating cell nuclear antigen and c

Proliferating cell nuclear antigen and c-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands

✍ Kyung-Ja Cho; Seung-Sook Lee; Yong-Sik Lee 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

Background. Adenoid cystic carcinoma (ACC) of the salivary gland shows a variable clinical course. It would be helpful to discover reliable biologic markers in the management of patients with ACC. Methods. We examined proliferating cell nuclear antigen (PCNA) and c-erbB-2 oncoprotein expression on